To investigate whether PKM2 inhibition by SMI or shRNA-PKM2 mediated anti-tumor effects in vivo, we first established xenografts using a slow growing H358 tumor cell line in athymic nude mice by implanting 5 x 106 cells. Here, PKM is linked to neoplasm.